Percentage of decrease in plasminogen binding, plasmin generation, and chemotaxis resulting from S100A10 depletion
Cell line . | Plasminogen binding, % . | Plasmin generation, % . | Chemotaxis, % . | Reference . |
---|---|---|---|---|
HT1080* (fibrosarcoma) | 28 | 80-95 | 60 | 71 |
CCL-222* (carcinoma) | 45 | 65 | 38 | 83 |
LLC* (carcinoma) | ND | 50 | 50 | Unpublished |
NB4* (APL) | 70 | 70 | 60 | 72 |
PR9* (histiomonocytic) | 72 | 49 | 55 | 72 |
Macrophage† | 30 | 45 | 50 | 73 |
TIME* (endothelial) | 50 | 62 | 74 | 53 |
MMEC† (endothelial) | 40 | 40 | 55 | 53 |
Cell line . | Plasminogen binding, % . | Plasmin generation, % . | Chemotaxis, % . | Reference . |
---|---|---|---|---|
HT1080* (fibrosarcoma) | 28 | 80-95 | 60 | 71 |
CCL-222* (carcinoma) | 45 | 65 | 38 | 83 |
LLC* (carcinoma) | ND | 50 | 50 | Unpublished |
NB4* (APL) | 70 | 70 | 60 | 72 |
PR9* (histiomonocytic) | 72 | 49 | 55 | 72 |
Macrophage† | 30 | 45 | 50 | 73 |
TIME* (endothelial) | 50 | 62 | 74 | 53 |
MMEC† (endothelial) | 40 | 40 | 55 | 53 |